Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003G67
CNY
170.61
0.11 (0.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

7.11 M

Shareholding (Mar 2026)

FII

0.02%

Held by 2 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company has declared Negative results for the last 3 consecutive quarters

  • NET PROFIT(HY) At CNY 4,940.88 MM has Grown at -33.91%
  • OPERATING CASH FLOW(Y) Lowest at CNY 8,641.15 MM
  • NET SALES(HY) At CNY 17,395.34 MM has Grown at -12.58%
2

With ROE of 24.07%, it has a expensive valuation with a 7.41 Price to Book Value

3

Majority shareholders : FIIs

 
4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 225,235 Million (Large Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.49%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

22.52%

stock-summary
Price to Book

5.73

Revenue and Profits:
Net Sales:
8,258 Million
(Quarterly Results - Mar 2026)
Net Profit:
2,427 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.96%
0%
-9.96%
6 Months
-17.1%
0%
-17.1%
1 Year
-24.46%
0%
-24.46%
2 Years
-44.02%
0%
-44.02%
3 Years
-43.35%
0%
-43.35%
4 Years
-44.25%
0%
-44.25%
5 Years
-59.95%
0%
-59.95%

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
10.29%
EBIT Growth (5y)
5.50%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.94
Tax Ratio
9.95%
Dividend Payout Ratio
65.07%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
76.50%
ROE (avg)
29.93%

Valuation key factors

Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
7.41
EV to EBIT
29.42
EV to EBITDA
24.87
EV to Capital Employed
12.33
EV to Sales
8.36
PEG Ratio
NA
Dividend Yield
2.07%
ROCE (Latest)
41.92%
ROE (Latest)
24.07%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1.50% vs -12.26% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -9.88% vs -14.84% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,257.70",
          "val2": "8,135.60",
          "chgp": "1.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,657.50",
          "val2": "3,048.90",
          "chgp": "-12.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.10",
          "val2": "5.00",
          "chgp": "22.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,426.50",
          "val2": "2,692.60",
          "chgp": "-9.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "321.80%",
          "val2": "321.80%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -10.97% vs 5.15% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -28.01% vs 1.40% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33,025.70",
          "val2": "37,093.70",
          "chgp": "-10.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11,043.10",
          "val2": "13,875.40",
          "chgp": "-20.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "103.60",
          "val2": "106.20",
          "chgp": "-2.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.10",
          "val2": "77.50",
          "chgp": "-118.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,451.50",
          "val2": "11,740.00",
          "chgp": "-28.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "281.50%",
          "val2": "333.50%",
          "chgp": "-5.20%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
8,257.70
8,135.60
1.50%
Operating Profit (PBDIT) excl Other Income
2,657.50
3,048.90
-12.84%
Interest
6.10
5.00
22.00%
Exceptional Items
1.00
0.00
Consolidate Net Profit
2,426.50
2,692.60
-9.88%
Operating Profit Margin (Excl OI)
321.80%
321.80%
NA
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 1.50% vs -12.26% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -9.88% vs -14.84% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
33,025.70
37,093.70
-10.97%
Operating Profit (PBDIT) excl Other Income
11,043.10
13,875.40
-20.41%
Interest
103.60
106.20
-2.45%
Exceptional Items
-14.10
77.50
-118.19%
Consolidate Net Profit
8,451.50
11,740.00
-28.01%
Operating Profit Margin (Excl OI)
281.50%
333.50%
-5.20%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -10.97% vs 5.15% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -28.01% vs 1.40% in Dec 2024

stock-summaryCompany CV
About Shenzhen Mindray Bio-Medical Electronics Co., Ltd. stock-summary
stock-summary
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available